Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Express Scripts
Baxter
AstraZeneca
Johnson and Johnson
McKinsey
Moodys

Last Updated: November 21, 2019

DrugPatentWatch Database Preview

Details for Patent: 6,821,975

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,821,975
Title: Beta-carboline drug products
Abstract:A compound of structural formula (I), and pharmaceutically acceptable salts and solvates thereof, wherein the compound is in free drug particulate form, is disclosed.
Inventor(s): Anderson; Neil R. (West Lafayette, IN), Hartauer; Kerry J. (Carmel, IN), Kral; Martha A. (Indianapolis, IN), Stephenson; Gregory A. (Fishers, IN)
Assignee: Lilly ICOS LLC (Wilmington, DE)
Application Number:10/031,463
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,821,975
Patent Claim Types:
see list of patent claims
Compound; Composition; Use;

Recent additions to Drugs Protected by US Patent 6,821,975

These patents are from the daily update and have not yet been integrated into the regular database
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Product Substance Delist Req. Patent Expiration Usecode Patented / Exclusive Use
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Type >RLD >Patent No. >Product >Substance >Delist Req. >Patent Expiration >Usecode >Patented / Exclusive Use

Drugs Protected by US Patent 6,821,975

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,821,975

PCT Information
PCT FiledAugust 01, 2000PCT Application Number:PCT/US00/20981
PCT Publication Date:February 08, 2001PCT Publication Number: WO01/08688

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Baxter
Moodys
Mallinckrodt
McKesson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.